Biospecimen Biorepository for the Study of ALS, ALS-FTD and Similar Neurodegenerative Disorders
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Mayo Clinic
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Blood plasma collection
研究概览
简要总结
The purpose of this study is to collect CSF and blood samples that can be used in future research studies to identify potential biomarkers in blood and cerebrospinal fluid (CSF) collected in Amyotrophic Lateral Sclerosis (ALS) patients.
详细描述
Biomarkers are non-genetic elements in your blood and CSF that may help diagnose and monitor ALS more easily. There are no readily available sources of longitudinal CSF, plasma or serum samples from people with ALS, ALS-FTD or similar neurodegenerative disorders or their family members for use in the identification of potential ALS biomarkers. Future research will examine potential biomarkers in blood and CSF collected over time to see if they change over time and can be used to diagnose and monitor people with ALS.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
Blood plasma collection
时间窗: 10 years
Total number of blood plasma samples collected
Cerebrospinal fluid collection
时间窗: 10 years
Total number of cerebrospinal fluid samples collected
Blood serum collection
时间窗: 10 years
Total number of blood serum samples collected
次要结局
未报告次要终点
研究者
Bjorn E. Oskarsson
Principal Investigator
Mayo Clinic